Eli Lillys daily anti-obesity pill orforglipron appears to be as good at spurring weight loss and lowering blood sugar in diabetes patients as popular injectable GLP-1 drugs like Ozempic, according to new data from a Phase 3 trial
The company is now selling Ozempic and Wegovy two of the most in-demand prescription medications in the U.S
This approval was notable because GLP-1s are typically taken by injection, which some patients find uncomfortable or difficult to maintain
A Narrative Review of BPC-157 for Musculoskeletal Healing | McGuire et al
Note that you should be open about your medical history, medications youre taking, and any other issue of interest, like if youre pregnant or breastfeeding, so that the medical practitioner can make an informed decision
Others describe delays in processing or difficulty confirming that their cancellation was received